Rioja-Blanco, E, Arroyo-Solera, I, Alamo, P, Casanova, I, Gallardo, A, Unzueta, U, Serna, N, Sanchez-Garcia, L, Quer, M, Villaverde, A, Vazquez, E, Leon, X, Alba-Castellon, L, Mangues, R. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2022; 41(1)DOI:10.1186/s13046-022-02267-8. PMID:35120582. IF:11.300(Q1/1D).

Cortes-Vicente, E, Alvarez-Velasco, R, Pla-Junca, F, Rojas-Garcia, R, Paradas, C, Sevilla, T, Casasnovas, C, Gomez-Caravaca, MT, Pardo, J, Ramos-Fransi, A, Pelayo-Negro, AL, Gutierrez-Gutierrez, G, Turon-Sans, J, de Munain, AL, Guerrero-Sola, A, Jerico, I, Martin, MA, Mendoza, MD, Moris, G, Velez-Gomez, B, Garcia-Sobrino, T, Pascual-Goni, E, Reyes-Leiva, D, Illa, I, Gallardo, E. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome. Annals of Clinical and Translational Neurology. 2022; 9(2)DOI:10.1002/acn3.51492. PMID:35080153. IF:5.300(Q1/2D).

Aracil-Bolanos, I, Martinez-Horta, S, Gonzalez-de-Echavarri, JM, Sampedro, F, Perez-Perez, J, Horta, A, Campolongo, A, Izquierdo, C, Gomez-Anson, B, Pagonabarraga, J, Kulisevsky, J. Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease. MOVEMENT DISORDERS. 2022; 37(2)DOI:10.1002/mds.28839. PMID:34752656. IF:8.600(Q1/1D).

Amoretti, S, Rosa, AR, Mezquida, G, Cabrera, B, Ribeiro, M, Molina, M, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Fraguas, D, Corripio, I, Vieta, E, de la Serna, E, Morro, L, Garriga, M, Torrent, C, Cuesta, MJ, Bernardo, M, PEPs Grp. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. PSYCHOLOGICAL MEDICINE. 2022; 52(3)DOI:10.1017/S0033291720002226. PMID:32900395. IF:6.900(Q1/1D).